Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1

Conditions

Pain 1Multiple Myeloma 1Mixed Dementias 1Lymphoma, Follicular 1Lymphoma 1Lewy Body Disease 1Dementia, Vascular 1Dementia 1Cognitive Dysfunction 1

Interventions

Cyclophosphamide 909Carboplatin 786pembrolizumab 741Paclitaxel 741Cisplatin 708Bevacizumab 705Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 335Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Has results × Referral and Consultation × Clear all
NCT05860127 2026-03-23

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

University of Massachusetts, Amherst

Phase NA Completed
133 enrolled 14 charts
Lymphoid

Mixed Dementias, Dementia, Lymphoma, Follicular, Dementia, Vascular, Lewy Body Disease, Cognitive Dysfunction

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed
51 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT01165281 2017-07-21

A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain

Janssen Research & Development, LLC

Phase 3 Completed
343 enrolled 15 charts

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡